New compounds which are active against the tissue forms of malar

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514314, 514895, 530330, 530331, A61K 3147, C07D21538, C07D21540, C07K 502

Patent

active

051109352

ABSTRACT:
The invention relates to new quinoline derivatives containing a free amine group and having antimalarial properties, in particular new primaquine derivatives or their addition salts with acids, and to a method for preparing them.
According to the invention, these new derivatives are represented schematically by the formula:

REFERENCES:
patent: 4703107 (1987-10-01), Monsyny et al.
patent: 4897267 (1990-01-01), Bontemps et al.
J. Med. Chem., vol. 31/1988, pp. 870-874, Philip et al.
J. Med. Chem., vol. 29, 1986, pp. 1765-1769, Hofsteenge et al.
Chem. Abst., vol. 99, #17, 1983, p. 637, #140345k, by Hu et al.
J. Med. Chem., vol. 31/1988, pp. 870-874, Philip et al., "Peptide derv. of primaquine . . . ".
Chem. Ab., vol. 99, #17, 1983, p. 637 #140345k, Hu et al., Peptide derv. of Primaquine.
El-Nagyru, CA 102:25012t, Synthesis of dipeptide derv. and studies of antimicrobial activities (1985).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

New compounds which are active against the tissue forms of malar does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New compounds which are active against the tissue forms of malar, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New compounds which are active against the tissue forms of malar will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1413386

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.